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sive IMN have an overexpression in tubular epithelial cells ofOverexpression of chemokines, fibrogenic cytokines, and myo-
the chemokines MCP-1, RANTES, and OPN and the profi-fibroblasts in human membranous nephropathy.
brogenic cytokines PDGF-BB and TGF-b. Because this up-Background. Proteinuria plays a central role in the progres-
regulation was associated with an interstitial accumulation ofsion of glomerular disease, and there is growing evidence sug-
mononuclear cells and an increase in myofibroblastic activity,gesting that it may determine tubular cell activation with
it is suggested that those mediators are potential predictors ofrelease of chemokines and fibrogenic factors, leading to inter-
progression in IMN. Finally, based on experimental data andstitial inflammatory reaction. However, most studies on this
the findings of this article, we speculate that severe proteinuriasubject have been performed in experimental models, and the
is the main factor responsible for the up-regulation of theseexperience in human kidney biopsies has been scarce. We ana-
factors in tubular epithelial cells.lyzed the tissue sections of patients with idiopathic membra-
nous nephropathy (IMN), a noninflammatory glomerular dis-
ease that may follow a progressive disease with heavy persistent
proteinuria, interstitial cell infiltration, and decline of renal In glomerular diseases, severe proteinuria usually isfunction.
associated with faster progression, and this correlationMethods. Paraffin-embedded biopsy specimens from 25 pa-
is even stronger for patients with nephrotic range pro-tients with IMN (13 progressive and 12 nonprogressive) were
retrospectively studied by immunohistochemistry [monocyte teinuria [1–3]. A highly significant correlation between
chemoattractant protein-1 (MCP-1), regulated on activation nor- baseline urinary protein excretion and subsequent glo-
mal T-cell expressed and secreted chemokine (RANTES), osteo- merular filtration rate decline has been shown [4]. More-pontin (OPN), platelet-derived growth factor-BB (PD-GF-BB)]
over, a number of studies in the last 10 years have indi-and in situ hybridization [MCP-1, RANTES, PDGF-BB, trans-
cated that in human glomerular diseases, the severity offorming growth factor-b1 (TGF-b1)]. Moreover, we studied
the presence of myofibroblasts, which were identified by the proteinuria correlated with tubulointerstitial infiltrates
expression of a-smooth muscle actin (a-SMA), the monocytes/ and that the degree of tubulointerstitial injury predicts
macrophages (CD68-positive cells), and T-cell infiltration renal function decline better than the severity of glomer-
(CD41 and CD81 cells). All of the patients were nephrotic
ular damage [5–9].and without treatment at time of the biopsy.
However, the mechanisms underlying the involvementResults. A strong up-regulation of MCP-1, RANTES, and
of the tubulointerstitium in progressive glomerulone-OPN expression was observed, mainly in tubular epithelial
cells, with a significant major intensity in the progressive IMN phritis remains largely unknown.
patients. A strong correlation between the mRNA expression There is a growing evidence that abnormal glomerular
and the corresponding protein was noted. The presence of permeability to proteins causes proximal tubular cell dys-these chemokines and OPN was associated with interstitial cell
function [1] and that proteinuria elicits tubular activa-infiltration. TGF-b and PDGF were also up-regulated, mainly
tion, with overexpression of chemokines [10–12] and fi-in tubular epithelial cells, with a stronger expression in the
progressive IMN, and an association with the presence of myo- brogenic cytokines [10, 13].
fibroblasts was found. In rats with protein-overload proteinuria, a model
Conclusions. Patients with severe proteinuria and progres- with interstitial inflammation [14], renal monocyte che-
moattractant protein-1 (MCP-1) mRNA and osteopon-
tin (OPN) mRNA levels were up-regulated, and MCP-1Key words: monocyte chemoattractant protein-1; osteopontin, growth
factors, proteinuria, idiopathic membranous nephropathy. protein was mainly localized in the tubules [10], sug-
gesting that both molecules could be implicated in inter-Received for publication February 18, 1999
stitial inflammation. More recently, in the experimentaland in revised form August 12, 1999
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of interstitial inflammation [12]. In addition to MCP-1 6, and 9), was done in 9 out of 13 patients, and was
confirmed in these patients because their disease pro-and OPN, a third powerful chemoattractant produced
by activated tubular cells has been proposed: regulated gressed to chronic renal failure during an average of 4.3
years (range 2 to 10) of clinical follow-up. The remainingon activation normal T-cell expressed and secreted che-
mokine (RANTES) [15]. four patients (cases 10 to 13) were biopsed and classified
as progressive during the last two years of the study,Besides the tubular cell activation and immune cell
infiltration, the presence of interstitial myofibroblasts based on the presence of a severe nephrotic syndrome,
a decrease in renal function, and interstitial cell infiltra-a-smooth muscle actin-positive (a-SMA1) cells, which
can be modulated by transforming growth factor-b tion. Case 10 had already progressed to chronic renal
failure during this time.(TGF-b) [16, 17] and platelet-derived growth factor
(PDGF) [18], has been proposed to be the main compo- The nonprogressive IMN patients were nephrotic and
with a stable renal function at the time of the biopsy.nent in the pathogenesis of tubulointerstitial injury [19].
In this study, we simultaneously analyzed the expres- They had no decline in renal function during the long-
term follow-up, which was between 3 and 25 years (meansion of MCP-1, RANTES, OPN, and profibrogenic cyto-
kines PDGF-BB and TGF-b by immunohistochemistry follow-up 11 years).
All of the patients were without treatment at the time(IMH) and in situ hybridization (ISH) in renal biopsy
sections of patients with human idiopathic membranous of the biopsy, and no patient had renal vein thrombosis.
The histologic diagnosis and determination of thenephropathy (IMN), as it is a noninflammatory glomeru-
lar disease characterized mainly by the presence of ne- stage of idiopathic MGN was done by light, fluorescence,
and electron microscopy. For light microscopy, kidneyphrotic proteinuria. As IMN may manifest a progressive
decline in renal function [20] and show persistently high tissues were fixed in 4% buffered formalin or Bouin
overnight, and were dehydrated and embedded in paraf-levels of urinary protein excretion and tubuloinsterstitial
lesions at biopsy, we also focused on the relationship fin by conventional techniques. Sections were stained
with hematoxylin and eosin (H&E), periodic acid-Schiffbetween chemokines and growth factor expression in
the presence of interstitial cell infiltration, particularly (PAS), and silver methenamine; some sections were
stained with Van Gieson in order to determine the pres-interstitial myofibroblasts (a-SMA positive cells), mono-
cyte/macrophages (CD68-positive cells), and T lympho- ence of interstitial collagen.
cytes (CD41 and CD81) in the tissue sections.
Immunohistochemistry
Paraffin-embedded biopsy specimens were used for de-
METHODS
tection of MCP-1, RANTES, OPN, PDGF-BB, a-SMA,
Human kidney specimens and CD68 (a marker of macrophages). Specific bio-
tinylated secondary antibodies that were followed withKidney samples were obtained by percutaneous renal
biopsy from patients undergoing diagnostic evaluation streptoavidin-horseradish peroxidase conjugate (Dako,
Carpinteria, CA, USA) and revealed with DAB wereat the Division of Nephrology, Austral University, Val-
divia, Chile. Control human kidney specimens (N 5 5) used.
The following primary antibodies were employed:were taken from normal portions of nephrectomy from
patients who underwent surgery because of localized MCP-1 (polyclonal goat antihuman, AB-279-NA; R&D
Systems, Minneapolis, MN, USA); RANTES (poly-renal tumors. Renal biopsies from 25 patients with idio-
pathic membranous glomerulonephropathy (MGN; 13 clonal goat antihuman, AB-278-NA; R&D Systems);
OPN (mouse monoclonal, MPIIIB10; DSHB, USA);with progressive IMN and 12 with nonprogressive IMN)
were studied. The diagnosis of IMN was made based on PDGF-BB (polyclonal rabbit antihuman, ZP-215; Gen-
zyme, Cambridge, MA, USA), b-SMA (mouse mono-clinical and histologic findings, and tests were done to
exclude secondary causes of membranous nephropathy. clonal a-SMA, 1A4; Dako), and CD68 (mouse mono-
clonal PG-M1; Dako). Briefly, 5-micron thick renalAll of the patients were screened for the presence of
antinuclear antibodies, anti-DNA antibodies, rheuma- sections, Bouin or formalin fixed and paraffin embedded,
were adhered to polylysine-covered glass and fixed over-toid factor, and hepatitis B antibodies. C3 and C4 were
in the normal range in all of the cases, and parasitic night at 568C. After deparaffinizing through xylene, alco-
hol, and distilled water, endogenous peroxidase wasinfections were discarded. Blood levels of carcinoembry-
onic antigen were determined when appropriate. Pa- blocked by 0.3% H2O2 for 20 minutes. The sections were
then treated in a microwave oven in a solution of citratetients who were exposed to any drug associated with this
disease were also excluded. buffer, pH 6.0, for 20 minutes and transferred to distilled
water. After rinsing in Tris-HCl phosphate-buffered sa-The classification of progressive IMN, based on the
presence of a severe nephrotic syndrome and a reduction line (TPS), the sections were incubated with 1:10 normal
rabbit serum in TPS/1% bovine serum albumin (BSA).of renal function at the time of the biopsy (cases 2,4, 5,
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Dako protein block serum-free (cat. X0909) was used tions were incubated with a prehybridization solution
containing 0.6 mol/L salt, 30% formamide, and 150with the anti–PDGF-BB antibody for 30 minutes at 228C.
The sections were then incubated overnight at 48C with mg/mL sonicated salmon sperm DNA for 60 minutes at
378C (R&D Systems).unlabeled polyclonal and monoclonal specific primary
antibodies. For the OPN, a-SMA, and CD68 staining, The hybridization reaction was performed overnight
at 378C with 100 mL of biotin-labeled probe cocktailsafter three rinses in TPS, the sections were incubated
with biotinylated rabbit antimouse in a 1:200 dilution in for each cytokine (200 ng/mL; R&D Systems) in a humid-
ified chamber.TPS-BSA 1%. For detection of RANTES and MCP-1,
the sections were incubated with biotinylated rabbit anti- Then the slides were washed twice with 4 3 SSC 30%
formamide, twice with 2 3 SSC 30% formamide, andgoat, dilution 1:300 in TPS-BSA 1%, and for the detec-
tion of PDGF-BB, the sections were incubated with bio- twice with 0.2 3 SSC 30% formamide at 378C for five
minutes, and then with 1 3 Tris-buffered saline (TBS)tinylated swine antirabbit dilution 1:100 in TPS-BSA 1%
for 30 minutes at 228C. Following three rinses in TPS, containing 2% Triton at room temperature for 15 min-
utes.they were then incubated with streptavidin-peroxidase
(Dako) 1:500 for 30 minutes. Color was developed with Detection was performed with avidin-alkaline phos-
phatase conjugate (Dako) for 30 minutes at room tem-diaminobenzidine, counterstained with hematoxylin, and
then dehydrated and mounted with Canadian balsam perature. It was washed for five minutes with 1 3 TBS
and using nitrobluetetrazolium (NBT) and 5-bromo-4-(Polysciences, Inc., Warrington, PA, USA). The speci-
ficity was checked by omission of primary antibodies and cloro-3-indolyl phosphate (BCIP) as the enzyme sub-
strate for 120 minutes at 378C in the dark (R&D Sys-use of nonimmune sera.
Cryostat sections (5 mm thick) from tissue fragments, tems). Tissues were then dehydrated in ethanol series
and mounted in Canadian balsam.frozen and kept in liquid nitrogen, were also used for the
detection of the macrophage marker CD68 (mouse mono- The specificity of the reaction was confirmed by: (a)
demonstrating the disappearance of hybridization signalclonal PG-M1; Dako) and for T lymphocytes CD4 (mono-
clonal mouse antihuman T cell, CD4, DAKO-CD4, when RNAse (100 mg/mL; Sigma) was added in 0.05
mol/L Tris after the digestion with proteinase K; (b) theMT310) and T cells CD8 (monoclonal mouse antihuman
T cell, CD8, DAKO-CD8, DK25). Specific biotinylated use of a sense probe (R&D Systems); (c) a negative
control (Plasmid DNA; Dako); and (d) without probe.secondary antibodies, followed by streptoavidin-horse-
radish peroxidase conjugate and revealed with DAB or
Immunohistochemistry coupled toAEC, were used. (Dako LSAB2 systems).
in situ hybridization
In situ hybridization This technique was performed to simultaneously de-
tect a-SMA–positive cells by IMH and cells expressingParaffin-embedded tissue sections, using different bio-
tin-labeled antisense probe cocktail specific for MCP-1, TGF-b by ISH on the same biopsy section, as well as to
simultaneously detect CD68-positive cells by IMH andRANTES, PDGF, TGF-b, followed with avidin-alkaline
phosphatase conjugate and BCIP/NBT (R&D Systems), MCP-1 by ISH. Renal sections of 5 micron thickness
fixed in 4% buffered formalin and embedded in paraffinwere used. The probes of biotin-labeled human MCP-1,
RANTES, PDGF, and TGF-b cocktail were purchased were sequentially treated for ISH and IMH as reported
previously in this article.from R&D Systems (Minneapolis, MN, USA).
Tissue preparation Immunohistological examination
Semiquantitative analysis was performed for the IMHTissue was fixed in 4% buffered formalin, embedded
in paraffin wax, and cut into 5 mm sections, which were and ISH by three different observers in a blinded fashion.
The staining distribution was scored separately in themounted onto 3-aminopropyltriethoxy-silane–coated slides
treated with diethylpyrocarbonate (DEPC; Sigma Chem- glomeruli and within the tubulointerstitium. The sections
were scored semiquantitatively for the proportion of pos-ical Co., St. Louis, MO, USA).
Tissue sections were dewaxed with xylene and rehy- itive cells according to the following 0 to 3 scale: 0 5 no
staining; 1 5 occasional staining; 2 5 focal staining; anddrated through a series of decreasing ethanol solutions.
Slide-mounted sections were treated with 2 3 standard 3 5 diffuse staining.
As tissue sections were run simultaneously for eachsaline citrate (SSC; 1 3 0.15 mol/L NaCl in 0.015
mol/L trisodium citrate, pH 7.0) at 608C for 10 minutes assay with the chemokines and growth factors studied
(protein and mRNA), it permitted an evaluation of theand were washed with DEPC-treated water.
Then tissue sections were digested with proteinase K staining intensity. The intensity of tubulointerstitial and
glomeruli staining in cortical areas was evaluated ac-(5 mg/mL) in 0.05 mol/L Tris (pH 7.6) for 60 minutes at
378C. After a wash with DEPC-treated water, the sec- cording to the following three-point scale observed at
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3250 magnification: 1 5 weak; 11 5 moderate; kines (MCP-1, RANTES, and OPN) was found. A very
111 5 strong intensity of staining. faint staining for PDGF was observed in these kidneys,
The mean value was obtained in both scoring systems particularly in the mesangium and the interstitium.
by dividing the total number of scores by the number of Expression of a-SMA was essentially confined to the
biopsies. media of arteries and arterioles. No staining was detected
Tubulointerstitial cell infiltration and interstitial fi- within the glomeruli, and a few sparse a-SMA–positive
brosis injury was classified into four groups according cells were detected in the peritubular interstitium. Very
to the extent of interstitial cell infiltration and cortical few macrophages were detected by the CD68 macro-
interstitial fibrosis and of tubular atrophy and degenera- phage marker.
tion: (a) normal, (b) involvement up to 25% of the cortex, In situ hybridization using riboprobes is a sensitive
(c) involvement of 26 to 50% of cortex, and (d) extensive method to study specific mRNA within tissue sections,
damage involving more than 50% of the cortex. as it allows a spatial analysis of expression. In the sections
Interstitial fibrosis was defined by the presence of in- of normal kidneys, no specific signal was detected for
terstitial collagen in sections stained with Van Gieson. MCP-1, RANTES, PDGF, and TGF-b.
Staining for a-SMA was particularly prominent in areas All sections hybridizated with a sense probe were neg-
of fibrosis around atrophic tubules. ative, and the binding of the antisense probes to these
The number of CD68-positive monocytes/macro- cells was prevented by preincubation with RNAse.
phages and T lymphocytes CD41 and CD81 in the
interstitium was counted using an ocular grid at a magni- Detection of proinflammatory chemokines (MCP-1,
fication of 3400. RANTES, OPN) in idiopathic membranous
nephropathy by immunohistochemistry and
Statistical analysis in situ hybridization
The results of the clinical data are expressed as the We observed a significant up-regulation of chemo-
mean 6 sd. The comparison between both groups was kines in almost all of the patients, mainly in tubular
performed by the Mann-Whitney U-test. Fisher’s test epithelial cells (Fig. 1), with a marked correlation be-
was used to analyze the risk factors of progression in tween the MCP-1 mRNA and RANTES mRNA expres-
each group. sion. On the other hand, the expression of these proin-
The score for the intensity and distribution of staining flammatory cytokines was significantly more intense in
for the IMH and the in situ hybridization in progressive the biopsies of patients with the progressive disease, with
and nonprogressive IMN is expressed as the mean 6
10 out of 13 patients having presented a severe nephroticsem. The comparison between both groups was done by
proteinuria lasting more than six months (Fig. 4).Mann-Whitney U-test. A P value , 0.05 was considered
We therefore wondered whether or not the increasedsignificant.
mRNA levels for MCP-1 and RANTES corresponded
to an increased protein synthesis. Indeed, as evaluated
RESULTS by IMH using a specific polyclonal antibodies, MCP-1
and RANTES protein expression, almost absent in nor-Clinical and histologic data
mal renal tissue, was present in 90% of the nephroticTable 1 summarizes the clinical and histologic data
patients with membranous nephropathy, with strongerfor each patient studied, and Table 2 illustrates the com-
immunostaining found in those with a progressive dis-parison between both groups of patients. There was not
ease and with a pattern similar to that observed fora significant difference between age and sex. However,
mRNA, mainly in tubular epithelial cells. Moreover, bythe progressive IMN was significantly associated with a
using serial consecutive biopsy sections, we observed thereduced renal function (serum creatinine .1.4 mg/dL)
gene and protein expression in the same tubular cellsat the time of the biopsy (P 5 0.0003). The mean arterial
(Figs. 3 a, b). In glomeruli, there was no mRNA up-pressure (MAP) over 110 mm Hg (P 5 0.0007), a persis-
regulation of these proinflammatory cytokines, but intent proteinuria $8 g/day for six months or longer (P 5
some cases, a mild glomerular inmunostaining for0.0007), advanced glomerular stages on biopsy (P 5
MCP-1, RANTES, and OPN was observed.0.003), tubulointerstitial cell infiltration (P 5 0.01), and
The expression of OPN was studied by IMH usingwith the interstitial fibrosis (P 5 0.002) confirmed the
only a monoclonal antibody. There was a clear immuno-prognostic value of these risk factors in patients with
staining for OPN in approximately 90% of the sectionsIMN [21].
studied that was mainly found in the tubular epithelial
Immunohistochemistry and in situ hybridization in cells, similar to MCP-1 and RANTES, and with a
normal control kidneys stronger expression in the patients with progressive IMN
(Fig. 4).Normal kidneys showed no glomerular staining, and
only sparse tubular and interstitial staining of the chemo- The increased gene and protein expression of these
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Table 1. Clinical data for patients with idiopathic membranous nephropathy (IMN)
Case Sex Age Creatinine Protein MAP Stage T.I.C.I. Int. Fib.
Progressive IMN
1 M 24 1.2 (1) 90 III 0 0
2 M 23 3.9 (1 1 1) 143 III 2 2
3 M 56 1.3 (1 1 1) 117 III 1 1
4 M 41 1.5 (1 1 1) 117 II 1 0
5 M 25 3.3 (1) 130 IV 1 2
6 F 63 1.5 (1 1 1) 107 IV 1 2
7 M 30 1.2 (1 1 1) 117 II 0 0
8 M 23 1.4 (1 1 1) 117 II 2 0
9 M 55 2.5 (1 1 1) 137 III 1 1
10 F 24 2.1 (1 1 1) 127 III 3 1
11 M 43 2.4 (1) 113 III 1 1
12 F 23 2.4 (1 1 1) 110 III 3 1
13 M 38 1.8 (1 1 1) 113 III 3 1
Nonprogressive IMN
14 M 42 0.9 (1) 93 II 1 0
15 M 37 1.0 (1) 77 III 2 1
16 F 70 0.9 (1) 110 III 0 0
17 M 50 1.2 (1) 127 II 0 0
18 M 50 1.0 (1) 103 II 0 0
19 F 52 0.7 (1) 97 II 0 0
20 F 43 0.9 (1) 90 II 0 0
21 M 35 1.0 (1) 100 II 1 0
22 M 40 1.2 (1) 83 II 0 0
23 M 22 1.2 (1 1 1) 103 II 1 0
24 F 47 0.8 (1) 83 II 0 0
25 F 44 1.1 (1) 103 II 0 0
Abbreviations are: Protein, urinary protein excretion (1): .3 g/day ,6 months; (1 1 1), .8 g/day .6 months; MAP, mean arterial pressure (mm Hg); T.I.C.I.,
tubulointerstitial cell infiltration; Int. Fib., interstitial fibrosis.
Table 2. Clinical and histological data
Progressive (13) Nonprogressive (12) P
Age years 36 (23–63) 44 (22–70) NS
Sex 10M/3F 7M/5F NS
Serum creatinine mg/dL 2.060.8 1.060.16 ,0.01
MAP mm Hg 118614 97614 ,0.01
Proteinuria .8 g/day .6 months 10/13 1/12 ,0.01
Histology Stages III & IV 10/13 2/12 ,0.01
Interstitial cell infiltration 11/13 4/12 ,0.01
Interstitial fibrosis 9/13 1/12 ,0.01
proinflammatory cytokines (MCP-1, RANTES, and patterns in those progressive patients who still did not
present a significant impairment of renal function (serumOPN) in the tubular epithelial cells was associated with
interstitial cell infiltration and with tubulointerstitial creatinine #1.5 mg/dL; cases 1, 3, 4, 6, 7, and 8) versus
the nonprogressive patients. The expression of these pro-damage (Fig. 1e). Furthermore, by using serial consecu-
tive biopsy sections, we observed the presence of some inflammatory cytokines remained significantly higher in
CD68-positive cells and mainly a-SMA–positive cells patients with progressive IMN.
(myofibroblats) around those structures in which cells
Expression of the profibrogenic cytokines PDGF-BBexpressed MCP-1, RANTES, and OPN (Fig. 2e).
and TGF-bAgain, the sections hybridizated with a sense probe
were negative, and binding of the antisense probes to Transforming growth factor-b expression was studied
only by ISH. TGF-b was up-regulated mainly in corticalthese cells was prevented by preincubation with RNAse.
As the progressive group not only differed in the mag- tubular epithelial cells, and this expression was signifi-
cantly higher in the group with progressive disease (100nitude of proteinuria, but also had significantly higher
blood pressures, more severe histology, and reduction vs. 40%, P 5 0.002; Fig. 2 c, d). Furthermore, this group
presented a significantly stronger TGF-b expression (Fig.in their renal function, we also compared the staining
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Fig. 1. Demonstration of monocyte chemoattractant protein-1 (MCP-1) mRNA by in situ hybridization (ISH), RANTES protein, and osteopontin
(OPN) protein by immunohistochemistry in idiopathic membranous nephritis (IMN; magnification 3300). (a) MCP-1 mRNA is strongly up-
regulated and mainly expressed by tubular epithelial cells in progressive IMN (case 12). (b) MCP-1 mRNA is weakly expressed in tubular epithelial
cells in a nonprogressive IMN (case 25). (c) RANTES protein staining is strongly increased in proximal tubular epithelial cells in progressive IMN
(case 10). (d) On the other hand, RANTES is weakly increased in tubular cells in a nonprogressive case of IMN (case 24). (e) Strong overexpression
of osteopontin protein in tubular epithelial cells in progressive IMN (case 13). Note the interstitial cell infiltration in close relationship with the
tubular osteopontin expression. ( f ) Negative staining for osteopontin in tubular epithelial cells in case of nonprogressive IMN [16].
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Fig. 2. Demonstration of platelet-derived growth factor (PDGF), transforming growth factor-b (TGF-b) by ISH, and a-smooth muscle actin
(a-SMA) by immunohistochemistry in IMN (magnification 3300). (a) Strong up-regulation of PDGF mRNA in tubular epithelial cells in progressive
IMN (case 5). (b) Weak up-regulation of PDGF mRNA in tubular epithelial cells in non progressive IMN (case 16). (c) Strong up-regulation of
TGF-b mRNA in tubular epithelial cells in progressive case of IMN (case 2). (d) TGF-b mRNA is not up-regulated in nonprogressive IMN case
(case 23). (e) Moderate increase in interstitial myofibroblats (a-SMA positive cells in renal interstitium) in a progressive IMN case (case 4). ( f )
Weak peritubular staining for a-SMA in a case of nonprogressive IMN (case 23).
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4). In general, the TGF-b mRNA expression was in- TGF-b, performed in some progressive cases, the immu-
nostaining for a-SMA was observed mainly in the peritu-creased in the tubulointerstitial area in a manner consis-
tent with the severity of the disease, and particularly, bular interstitium and TGF-b mRNA expression local-
ized in the surrounding tubular epithelial cells (Fig. 3c).the proximal and distal tubules surrounded by interstitial
mononuclear cells were positive (Fig. 3c). At the glomer- Although the tubular interstitial cell infiltration was
found in almost all of the progressive IMN biopsy sec-ular level, we found a weak expression of this growth
factor in some patients. tions, not many cells were recognized as macrophages/
monocytes, according to the immunostaining for CD68Platelet-derived growth factor mRNA expression was
consistent with the expression of TGF-b and was ob- (Fig. 3d). For these reasons and to characterize the mo-
nonuclear cell populations infiltrating the interstitium,served mainly in cortical tubular epithelial cells and pri-
marily in the cases with progressive disease (9 out of 11 we looked for the presence of other immune cells, such
as CD41 and CD81 lymphocytes. Increased numbersvs. 3 out of 9, P 5 0.03; Fig. 2 a, b). Furthermore, PDGF
mRNA up-regulation was significantly stronger in pro- of cells with the CD4 and CD8 phenotype were found
in the renal interstitium of sections of the progressivegressive IMN (Fig. 4).
Immunostaining for PDGF-BB protein was correlated patients, and as can be seen in Figure 3 e and f, these
were mainly CD41 cells.with the mRNA expression, and it was mainly expressed
in tubular epithelial cells, with a staining score signifi-
cantly higher in those with progressive disease.
DISCUSSION
When we compared the staining patterns in those pro-
Human progressive IMN is characterized by a de-gressive patients who were without a significant impair-
crease in renal function, persistent nephrotic proteinuriament of renal function (cases 1, 3, 4, 6, 7, and 8) versus
and interstitial cell infiltration [20, 21]. Growing evidencethe nonprogressive patients, the expression of the profi-
suggests that infiltrating immune cells could be recruitedbrogenic cytokines was already significantly higher in
within interstitial areas by three powerful chemoattrac-patients with progressive IMN.
tants produced by activated tubular cells such as MCP-1,Again, because all of these IMH and ISH studies for
RANTES, and OPN [1, 15, 22, 23]. MCP-1 and RANTESeach chemokine and fibrogenic factor were separately
belong to the family of C-C chemokines [reviewed in 24],but simultaneously performed in all of the tissue sections
and OPN is a secreted acidic glycoprotein that has potentstudied, it allowed us to score them semiquantitatively
monocyte chemoattractant and adhesive properties [25].and to compare the staining intensities.
Our results document that the C-C chemokines, MCP-1,
Interstitial myofibroblast and macrophage infiltration RANTES, and OPN, are involved in the evolution of
in idiopathic membranous nephropathy progressive IMN. A strong up-regulation of MCP-1,
RANTES (mRNA and protein) and OPN protein wasTo characterize the proliferating cells in the tubuloin-
demonstrated, mainly in the cortical tubular epithelialterstitial area, tissue sections were immunostained with
cells in renal tissue sections of patients with a progressivemonoclonal antibodies to identify monocyte/macro-
disease. On the other hand, the expression of MCP-1,phage (cells positive for CD68) or myofibroblasts (cells
RANTES, and OPN was significantly milder in patientspositive for a-SMA).
with a nonprogressive disease (Fig. 4).a-Smooth muscle actin interstitial-positive cells were
The strong up-regulation of these chemokines, mainlymainly detected in patients with a progressive disease
localized in the tubules, is consistent with the up-regula-(13 out of 13 progressive vs. 4 out of 12 with nonprogres-
tion of MCP-1 and OPN observed in the rat with protein-sive, P 5 0.0004; Fig. 2 e, f). The staining distribution
overload proteinuria [10] and with Heymann nephritis,was mainly in the peritubular and periglomerular cortical
an experimental form of membranous nephropathyinterstitium, and there was a stronger expression in the
[12, 23], and suggests that in human IMN the tubularpatients with a progressive IMN and a weak staining in
protein overload up-regulates these inflammatory genes.some positive nonprogressive cases (Fig. 4). The pres-
In situ analysis of C-C chemokine expression in humanence of myofibroblasts was significantly associated with
glomerulonephritis is mainly limited to MCP-1 [26]. Re-the tubular interstitial cell infiltration (P 5 0.02), intersti-
cently, Gesualdo et al demonstrated the expression oftial fibrosis (P 5 0.005), and the severity of the protein-
MCP-1 mRNA and protein in cryoglobulinemic mem-uria (P 5 0.03).
branoproliferative glomerulonephritis localized to mac-In four progressive and three nonprogressive cases,
rophages and other infiltrating and resident cells [27]. Ina-SMA–positive cells were observed at the glomerular
renal biopsies from a heterogeneous group of patientslevel, which represents a phenotypic modulation of acti-
with glomerulonephritis, Prodjosudjadi et al analyzedvated mesangial cell. The cell expression was not associ-
MCP-1 protein expression at glomerular and interstitialated with a higher incidence of glomerulosclerosis.
In a double IMH to a-SMA coupled with ISH for sites, but found no correlation between glomerular
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Fig. 3. (a) Demonstration of MCP-1 mRNA and (b) protein in progressive IMN (case 11; magnification 3300). Serial sections of the same biopsy
show that MCP-1 mRNA (a) and protein (b) are strongly expressed in tubular epithelial cells. The distribution of MCP-1 mRNA and protein is
similar. (c) Immunohistochemistry coupled with ISH for a-SMA positive cells and TGF-b. A moderate increase in interstitial a-SMA is associated
with TGF-b mRNA up-regulation in close tubular epithelial cells. (d) CD68-positive cells in progressive IMN (case 10). Paraffin section (magnification
3300). (e) CD41 T-cell lymphocytes in renal interstitium (case 13). Cryostat section (magnification 3300). ( f ) CD81 T-cell lymphocytes in
interstitium (case 13). Cryostat section (magnification 3300).
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Fig. 4. Schematic summary of chemokines,
profibrogenic cytokines, and a-SMA expres-
sion in progressive (h) and nonprogressive
IMN ( ). The results of the IMH or ISH
staining scores are presented as the mean 6
sem. *P , 0.05.
MCP-1 expression and intraglomerular macrophage in- mainly in the heavily proteinuric progressive IMN pa-
tients, clearly suggests an active and central role forfiltration [28]. In membranous nephropathy, an associa-
tubular epithelial cells in the pathological events involv-tion was found between the intensity of MCP-1 staining
ing the renal interstitium. Our data support the hypothe-in tubular epithelial cells and interstitial infiltration of
sis of Remuzzi, Ruggenenti, and Begnini [1], who havemacrophages. Grandaliano et al showed an increased
suggested that the increased intracellular trafficking ofMCP-1 gene and protein expression in IgA nephropathy,
proteins in the tubules could activate the transcriptionmainly in cortical tubular epithelial cells, infiltrating
factor nuclear factor-kB and consequently increase themononuclear cells, as well as glomerular parietal cells,
expression of a variety of proinflammatory genes (MCP-1,which correlated with the presence and the extent of
RANTES, and OPN), inducing the recruitment of in-monocyte infiltration and with the severity of the tubulo-
flammatory cells.interstitial lesions [22]. In biopsies of systemic lupus ery-
Although we found a significant interstitial cell infil-thematosus (SLE) patients, Wada et al detected MCP-1
tration mainly in progressive IMN, our data also suggestgene and protein in infiltrating monocytes and in cortical
that C-C chemokines and OPN might recruit immunetubular cells, but surprisingly not in glomeruli [29]. Fi-
cells other than macrophages/monocytes, such as CD41nally, Cockwell et al examined the C-C chemokine ex-
and CD81 T lymphocytes. CD41 and CD81 lympho-pression in a range of human inflammatory glomerulo-
cytes and macrophages were found to accumulate intonephritis, demonstrating the concurrent expression of
the renal interstitium in animals with protein-overflowMCP-1, MIP-1, and RANTES mRNAs by glomerular
proteinuria [14] and more recently in another nonimmuneand tubular epithelial cells and colocalizing much of this
model of proteinuric rats with renal mass reduction [31].expression to infiltrating macrophages [30].
Our current data also show a strong increase of tubulo-
On the whole, in different human glomerular diseases,
epithelial cells expressing PDGF-BB (mRNA and protein)
a tubular expression of MCP-1 has been observed that and TGF-b mRNA, which significantly correlates with
is correlated with the monocyte/macrophage infiltration, the degree of tubulointerstitial damage and with the pres-
mainly in the interstitium. ence of interstitial myofibroblasts (a-SMA–positive cells).
Evidence about the potential role of OPN in glomeru- Tubulointerstitial injury is an important component
lar diseases is mainly derived from observations in ex- in the assessment of renal damage because it correlates
perimental models of mesangial proliferative nephritis well with the decline in renal function and long-term pro-
(anti-Thy1 nephritis), focal segmental sclerosis (amino- gression [32, 33]. In addition, tubular cell injury as a result
nucleoside nephrosis), and membranous nephropathy of chronic ischemia and/or filtered plasma proteins could
(passive Heymann nephritis). These data suggest that: be crucial in the process of tubulointerstitial fibrosis [13].
(a) OPN is up-regulated in tubules in glomerular disease; Many potentially fibrogenic factors, including TGF-b,
(b) OPN may be important for macrophage accumula- have been implicated in tubulointerstitial injury; how-
tion at specific sites during tissue damage; and (c) OPN ever, the role of growth factors in the progression of
may have a role in the pathogenesis of the tubulointersti- tubulointerstitial fibrosis remains poorly understood [10,
tial injury that accompanies glomerulonephritis [12, 23]. 34]. With respect to the source of fibrogenic growth fac-
Indeed, in our study, the increased tubular expression tors in the kidney, macrophages and mesangial cells have
thus far received the most attention.of C-C chemokines, OPN, and fibrogenic growth factors,
Mezzano et al: Chemokines and fibrogenic factors in human IMN 157
Myofibroblasts are terminally differentiated cells with REFERENCES
morphologic features intermediate between those of fi- 1. Remuzzi G, Ruggenenti P, Begnini A: Understanding the nature
broblasts and smooth muscle cells. Thus, the cell retains of renal disease progression. Kidney Int 51:2–15, 1997
2. Gansevoort RT, Navis GJ, Wapstra FH, De Jong PE, De Zeeuwthe biologic properties of fibroblast synthesizing intersti-
D: Proteinuria and progression of renal disease: Therapeutic impli-tial collagens I and III, and at the same time, it expresses cations. Curr Opin Nephrol Hypertens 6:133–140, 1997
a-SMA, characteristic of the vascular smooth muscle 3. Jungers P, Hannedouche T, Itakura Y, Albouze G, Descamps-
Latscha B, Mann NK: Progression rate to end-stage renal failurecell [35, 36]. Although the origin of the myofibroblast
in non diabetic kidney diseases: A multivariate analysis of determi-remains unknown, Tang et al have recently shown the nant factors. Nephrol Dial Transplant 10:1353–1360, 1995
important role for the myofibroblasts in the pathogenesis 4. The GISEN Group (Gruppo Italiano Di Studi Epidemiologici
In Nefrologia): Randomised placebo-controlled trial of effect ofof tubulointerstitial fibrosis by infiltrating the tubulointer-
ramipril on decline in glomerular filtration rate and risk of terminalstitium and as the source of a1(III) collagen [36]. On the renal failure in proteinuric, non diabetic nephropathy. Lancet
other hand, TGF-b [17] and mainly PDGF-BB [18, 37] 349:1857–1863, 1997
5. Bohle A, Wehrmann M, MacKensen-Haen S, Gise HV, Mick-were shown to induce transformation of fibroblasts to
Eler E, Xiao TC, Muller C, Muller GA: Pathogenesis of chronicmyofibroblasts, which are major contributors to matrix renal failure in primary glomerulonephritis. Nephrol Dial Trans-
deposition in the tubulointerstitial area. plant S 3:4–12, 1994
6. Wehrmann M, Bohle A, Bogenschutz O, Eissele R, Freisle-Moreover, recently Ito et al have reported a local
Derer A, Ohlschlegel C, Schumm G, Batz C, Gartner H-V:increase of connective tissue growth factor (CTGF) in Long term prognosis of chronic idiopathic membranous glomerulo-
human renal fibrosis [38]. This novel growth factor is nephritis. Clin Nephrol 31:67–76, 1989
7. MacKensen-Haen R, Eissele R, Bohle A: Contribution on thestrongly up-regulated by TGF-b and is coexpressed in
correlation between morphometric parameters gained from thea-SMA cells in the tubulointerstitial area. Finally, extra-
renal cortex and renal function in IgA nephritis. Lab Invest 59:239–
cellular matrix production and/or deposition could also 244, 1988
8. MacKensen-Haen S, Bohle A, Christensen J, Wehrmann M,be influenced by the presence of MCP-1, either directly
Kendziorra H, Kokot F: The consequences for renal function ofas a fibrogenic factor, or indirectly through TGF-b, thus
widening of the interstitium and changes in the tubular epithelium
contributing to the development of fibrosis [24]. of renal cortex and outer medulla in various renal diseases. Clin
Nephrol 37:70–77, 1992In our patients, the presence of myofibroblasts within
9. Nath KA: Tubulointerstitial disease as a major determinant ofthe renal interstitium correlates with the extent of tubu-
progressive renal injury. Am J Kidney Dis 20:1–17, 1992
lointerstitial scarring and functional outcome, confirming 10. Eddy AA, Giachelli CM, McCulloch L, Liu E: Renal expression
of genes that promote interstitial inflammation and fibrosis in ratsother clinical [39–41] and experimental studies [42, 43],
with protein-overload proteinuria. Kidney Int 47:1546–1557, 1995postulating that the myofibroblasts proliferation can be
11. Wang Y, Chen J, Chen L, Tay Y-C, Rangan GK, Harris DCH:
detected before the presence of significant fibrosis, and Induction of monocyte chemoattractant protein-1 in proximal tu-
bule cells by urinary protein. J Am Soc Nephrol 8:1537–1545, 1997suggesting that they may be potentially used as early
12. Abbate M, Zoja C, Corna D, Capitano M, Bertani T, Remuzzimarkers of progressive disease.
G: In progressive nephropathies, overload of tubular cells withIn conclusion, our results show that MCP-1, RANTES, filtered proteins translates glomerular permeability dysfunction
and OPN are overexpressed in tubular epithelial cells of into cellular signals of interstitial inflammation. J Am Soc Nephrol
9:1213–1224, 1998patients with more severe and progressive IMN, and that
13. Ong AC, Fine LG: Tubular-derived growth factors and cytokinesthey could participate in the interstitial inflammatory in the pathogenesis of tubulointerstitial fibrosis: Implications for
reaction. Based on the experimental observations, we human renal disease progression. Am J Kidney Dis 23:205–209,
1994suggest that severe proteinuria is the main factor respon-
14. Eddy AA, McCulloch L, Adams J, Liu E: Interstitial nephritissible for the up-regulation of these factors in tubular
induced by protein-overload proteinuria. Am J Pathol 135:719–733,
epithelial cells. The profibrogenic cytokines PDGF-BB 1989
and TGF-b are also up-regulated in tubular epithelial 15. Heeger P, Wolf G, Meyers C, Sun MJ, O’Farrell SC, Krensky
AM, Neilson EG: Isolation and characterization of cDNA fromcells, mainly in the patients with progressive disease,
renal tubular epithelium encoding murine RANTES. Kidney Intand both growth factors could modulate the interstitial 41:220–225, 1992
myofibroblastic activity and be potential predictors of 16. Border WA, Noble NA: TGF-b in kidney fibrosis: A target for
gene therapy. Kidney Int 51:1388–1396, 1997progression in IMN.
17. Desmoulie`re A, Geinoz A, Gabbiani F, Gabbiani G: Trans-
forming growth factor-b1 induces a-smooth muscle actin expres-
ACKNOWLEDGMENTS sion in granulation tissue myofibroblasts and in quiescent and grow-
ing cultured fibroblasts. J Cell Biol 122:103–111, 1993This work was supported by research grant from Fondo Nacional de
18. Tang WW, Ulich TR, Lacey DL, Hill DC, Qi M, Kaufman SA,Investigacio´n Cientı´fica y Tecnolo´gica, Chile (FONDECYT 1970628)
Van Gy Tarpley JE, Yee JS: Platelet-derived growth factor-BBand received support from the Direccio´n de Investigacio´n, Universidad
induces renal tubulointerstitial myofibroblast formation and tubu-Austral, Valdivia, Chile. Reproduction of the color figures was sup-
lointerstitial fibrosis. Am J Pathol 148:1169–1180, 1996ported in part by Roche Chile. A portion of this study was presented
19. Okada H, Strutz F, Danoff TM, Neilson EG: Possible pathogen-at the 31st Annual Meeting of the American Society of Nephrology,
esis of renal fibrosis. Kidney Int 49(Suppl 54):S37–S38, 1996Philadelphia, October 1998.
20. Wasserstein AG: Membranous glomerulonephritis. J Am Soc
Nephrol 8:664–674, 1997Reprint requests to Sergio Mezzano, M.D., Department of Nephrology,
21. Reichert LJ, Koene RA, Wetzels JF: Prognostic factors in idio-School of Medicine, Universidad Austral, P.O. Box 8-D, Valdivia, Chile.
E-mail: smezzano@uach.cl pathic membranous nephropathy. Am J Kidney Dis 31:1–11, 1998
Mezzano et al: Chemokines and fibrogenic factors in human IMN158
22. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Montinaro 32. Risdon RA, Sloper JC, De Wardener HE: Relationship between
renal function and histological changes found in renal-biopsy speci-V, Marra F, Schena FP: Monocyte chemotactic peptide-1 expres-
sion in acute and chronic human nephritides: A pathogenetic role mens from patients with persistent glomerular nephritis. Lancet
2:363–366, 1968in interstitial monocytes recruitment. J Am Soc Nephrol 7:906–913,
1996 33. Schainuck LI, Stricker GE, Cutler RE, Benditt EP: Structural-
functional correlations in renal disease. II. The correlations. Hum23. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K,
Alpers CE, Schwartz SM, Johnson RJ: Tubulointerstitial disease Pathol 1:631–641, 1970
34. Yamamoto T, Noble NA, Miller DE, Border WA: Sustainedin glomerulonephritis: Potential role of osteopontin (uropontin).
Am J Pathol 144:915–926, 1994 expression of TGF-b1 underlies development of progressive kid-
ney fibrosis. Kidney Int 45:916–927, 199424. Lloyd C, Gutierrez-Ramos JC: The role of chemokines in tissue
inflammation and autoimmunity in renal diseases. Curr Opin 35. Gabbiani G: The biology of the myofibroblast. Kidney Int 41:530–
532, 1992Nephrol Hypertens 7:281–287, 1998
25. Giachelli CM, Schwartz SM, Liaw L: Molecular and cellular 36. Tang WW, Van Gy QIM: Myofibroblast and a1 (III) collagen
expression in experimental tubulointerstitial nephritis. Kidney Intbiology of osteopontin: Potential role in cardiovascular disease.
Trends Cardiovasc Med 5:88–95, 1995 51:926–931, 1997
37. Stein-Oakley AN, Maguire JA, Dowling J, Perry G, Thomson26. Schlondorff D, Nelson PJ, Luckow B, Banas B: Chemokines
and renal disease. Kidney Int 51:610–621, 1997 NM: Altered expression of fibrogenic growth factors in IgA ne-
phropathy and focal and segmental glomerulosclerosis. Kidney Int27. Gesualdo L, Grandaliano G, Ranieri E, Monno R, Montinaro
V, Manno C, Schena FP: Monocyte recruitment in cryoglobuli- 51:195–204, 1997
38. Ito J, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ,nemic membranoproliferative glomerulonephritis: A pathogenic
role for monocyte chemotactic peptide-1. Kidney Int 51:155–163, Glodschmeding R: Expression of connective tissue growth factor
in human renal fibrosis. Kidney Int 53:853–861, 19981997
28. Prodjosudjadi W, Gerritsma JS, Vanes LA, Daha MR, Brujin 39. Roberts IS, Burrows C, Shanks JH, Venning M, McWilliam
LJ: Interstitial myofibroblasts: Predictors of progression in mem-JA: Monocyte chemoattractant protein-1 in normal and diseased
human kidneys: An immunohistochemical analysis. Clin Nephrol branous nephropathy. J Clin Pathol 50:123–127, 1997
40. Alpers CE, Hudkins KL, Floege J, Johnson RJ: Human renal44:148–155, 1995
29. Wada T, Yokoyama H, Su S-B, Mukaida N, Iwano M, Dohi K, cortical interstitial cells with some features of smooth muscle cells
participate in tubulointerstitial and crescentic glomerular injury.Takahashi Y, Sasaki T, Furuichi K, Segawa C, Hisada I, Ohta S,
Takasawa K, Kobayashi K-I, Matsushima K: Monitoring urinary J Am Soc Nephrol 5:201–210, 1994
41. Goumenos DS, Brown CB, Shortland JEL, Nahas AM: Myofi-levels of monocyte chemotactic and activating factor reflects dis-
ease activity of lupus nephritis. Kidney Int 49:761–767, 1996 broblasts, predictors of progression of mesangial IgA nephropa-
thy? Nephrol Dial Transplant 9:1418–1425, 199430. Cockwell P, Howie AJ, Adu D, Savage CO: In situ analysis of
C-C chemokine mRNA in human glomerulonephritis. Kidney Int 42. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG,
Koch KM, Floege J: Mechanisms involved in the pathogenesis of54:827–836, 1998
31. Remuzzi G, Zoja C, Gagliardini E, Corna D, Abbate M, Begnini tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int
49:666–678, 1996A: Combining an antiproteinuric approach with mycophenolate
mofetil fully suppresses progressive nephropathy of experimental 43. Diamond JR, Van Goor H, Ding G, Engelmyer E: Myofibroblasts
in experimental hydronephrosis. Am J Pathol 146:121–129, 1995animals. J Am Soc Nephrol 10:1542–1549, 1999
